Related Content
March 7, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions for ...
December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic myocardial ...
June 30, 2020 — BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The ...
October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...